NASDAQ:PFSA Profusa (PFSA) Stock Price, News & Analysis $0.32 -0.02 (-6.40%) Closing price 11/20/2026 04:00 PM EasternExtended Trading$0.33 +0.00 (+1.42%) As of 11/20/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider TradesNews and TrendsSEC Filings About Profusa Stock (NASDAQ:PFSA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Profusa alerts:Sign Up Key Stats Today's Range$0.31▼$0.3550-Day Range$0.32▼$3.0352-Week Range$0.31▼$1,516.50Volume162,965 shsAverage Volume668,501 shsMarket Capitalization$1.84 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Profusa is a medical technology company developing biosensors designed to measure changes in the body’s chemistry continuously. Its platform uses small, tissue-integrated sensors that generate signals a wearable reader can detect and relay for analysis. The company’s Lumee Oxygen platform is designed to monitor oxygen levels in tissue. Profusa has focused on applications where local oxygen measurements may help clinicians assess tissue health, including care involving peripheral artery disease. Profusa’s technology combines its biosensors with reader and software components to collect and display measurement data. The company is based in the United States and continues to develop its sensing platform for medical and other health-related applications.AI Generated. May Contain Errors. Read More Profusa Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks3rd Percentile Overall ScorePFSA MarketRank™: 0.13818742985 of 5 starsProfusa scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingProfusa has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageProfusa has only been the subject of 1 research reports in the past 90 days.Read more about Profusa's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Profusa is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Profusa is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioProfusa has a P/B Ratio of 0.24. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted19.13% of the float of Profusa has been sold short.Short Interest Ratio / Days to CoverProfusa has a short interest ratio ("days to cover") of 0.02, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Profusa has recently increased by 26.55%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldProfusa does not currently pay a dividend.Dividend GrowthProfusa does not have a long track record of dividend growth. News and Social Media0.0 / 5News SentimentN/A Search InterestOnly 1 people have searched for PFSA on MarketBeat in the last 30 days. This is a decrease of -89% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Profusa insiders have not sold or bought any company stock.Percentage Held by Insiders15.00% of the stock of Profusa is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions9.81% of the stock of Profusa is held by institutions.Read more about Profusa's insider trading history. Receive PFSA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Profusa and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PFSA Stock News HeadlinesProfusa Announces Progress Towards Satisfying the Conditions to Close of the Option Agreement with G3November 12, 2026 | globenewswire.comProfusa Amends Promissory Note Conversion Pricing TermsNovember 6, 2026 | tipranks.comYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on Elon Musk's next big industry play. He estimates it could create 1.8 million new millionaires in the coming years, and shows how to position in the company at its center for under $60. Inside: the company's name and ticker, plus an FCC filing James believes reveals Elon's plan to take over a $25 trillion industry. He also flags December 8 as a key date.November 22 at 1:00 AM | Paradigm Press (Ad)Profusa Receives ISO 13485:2016 Certificate from GMEDOctober 15, 2026 | globenewswire.comProfusa Announces Significant Progress towards Lumee Oxygen Platform CE Mark with ISO 13485 certification Expected in Early OctoberSeptember 25, 2026 | marketscreener.comMHere’s What Investors Are Watching, Including $20 Price Target BombshellSeptember 24, 2026 | markets.businessinsider.comProfusa ISO 13485 certification decision advances Lumee oxygen platform toward CE markSeptember 24, 2026 | msn.comMicro Cap Profusa Navigates European Regulatory Hurdles to Advance Oxygen Monitoring TechSeptember 24, 2026 | benzinga.comSee More Headlines PFSA Stock Analysis - Frequently Asked Questions How have PFSA shares performed this year? Profusa's stock was trading at $786.00 at the beginning of the year. Since then, PFSA shares have decreased by 100.0% and is now trading at $0.3234. How were Profusa's earnings last quarter? Profusa, Inc. (NASDAQ:PFSA) released its quarterly earnings data on Friday, November, 13th. The company reported ($6.23) EPS for the quarter. When did Profusa's stock split? Shares of Profusa reverse split before market open on Monday, February 9th 2026.The 1-75 reverse split was announced on Thursday, February 5th 2026. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 6th 2026. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. How do I buy shares of Profusa? Shares of PFSA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings11/13/2026Today11/22/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2w+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 2 weeks, PFSA's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:PFSA CIK1859807 Webprofusa.com Phone(212) 494-9022FaxN/AEmployees2Year Founded2009Profitability EPS (Trailing Twelve Months)($363.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$35.82 million Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-252.60% Debt Debt-to-Equity RatioN/A Current Ratio0.02 Quick Ratio0.03 Sales & Book Value Annual Sales$100 thousand Price / Sales18.37 Cash FlowN/A Price / Cash FlowN/A Book Value$1.37 per share Price / Book0.24Miscellaneous Outstanding Shares5,680,000Free Float4,830,000Market Cap$1.84 million OptionableN/A Beta0.62 Social Links 7 Energy Stocks to Buy and Hold ForeverOil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.Get This Free Report This page (NASDAQ:PFSA) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredThe warning signs most investors see too lateDr. Martin D. Weiss has publicly predicted six major American crashes since founding Weiss Ratings in 1971. ...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profusa, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Profusa With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.